Pre-Eclampsia Clinical Trial
Official title:
Role and Expression of Matrix-remodelling Associated 5 Protein (MXRA5) in Connective Tissue Remodelling of Placenta in Preeclampsia
1. To measure the level of expression of MXRA5 and ANXA4 genes in preeclampsia (PE).
2. To detect the effect of heavy metals (lead (Pb) and arsenic (AR)) on these two genes in
the pathology of PE.
3. To explore the association of the previous two genes with the heavy metals in link with
Phosphoinositide 3-kinases/Protein Kinase B (PI3K/AKT) pathway.
4. To detect Syndecan-1 by immunohistochemical antibodies.
5. To define the role of extracellular matrix remodelling in PE.
- Preeclampsia (PE) is a diverse multisystem syndrome defined as a new onset of
hypertension along with evidence of significant multiorgan dysfunction in previously
normotensive women 20 weeks of gestation (1)
- The incidence of PE is around 2 - 8 % of pregnancies and it causes about 50,000 deaths
worldwide every year (2).
- In Egypt, it complicates 6% - 8% of pregnancies (3).
- Placentation processes include trophoblastic invasion, vascularization of trophoblast to
establish and maintain feto-placental vasculature, and subsequent maternal vascular
remodeling (4). Extravillous trophoblastic (EVT) cells are crucial for this process (5).
If the function of extravillous trophoblast cells is deficient, it can result in PE (6).
- PI3K/AKT pathway plays important roles in placental development and fetal growth (7).
PI3K/AKT signaling pathway is important for cell proliferation, migration, invasion and
glycolysis/gluconeogenesis (8). AKT can further activate different downstream factors,
which plays a predominant role in angiogenesis, vascular permeability and migration (9).
- Matrix metalloproteinase (MMPs) are essential proteases for trophoblast invasion and
migration as they promote degrading of the extracellular matrix improving the the cell
invasion, while the tissue inhibitors of matrix metalloproteinases (TIMPs) are normal
tissue proteins that inhibit the action of MMPs (10).
- Annexin A4 (ANXA4) has been shown to participate in regulation of cellular growth,
invasion, and apoptosis. ANXA4 has role in many forms of cancer (11). It was found that
ANXA4 expression was downregulated in PE placentas compared with the normal placentas.
However, the exact role of ANXA4 in the invasion and survival of trophoblast cells
remains less understood.
- ANXA4 binds to the plasma membrane in a Ca2+- dependent manner and regulates its
downstream signaling transduction, including phosphoinositide-3-kinase PI3K/AKT
signalling (12).
- Matrix-remodelling associated 5 (MXRA5) is a member of the MXRA protein family,
participating in cell adhesion and extracellular matrix remodelling (13). This protein
is expressed in primates but not in rat or mouse. The function of this protein remains
elusive. It resembles the vascular endothelial growth factor (VEGF) receptor and has
anti-inflammatory and anti-fibrotic properties (14). Somatic mutations of MXRA5 are
found in non-small cell lung cancer and in colorectal cancer (15).
- The expression of MXRA5 was shown to be downregulated in the placentae of PE patients
which consequently leads to the inhibition of PI3k/AKT pathway (16).
- As regard that both of ANXA4 and MXRA5 downregulate PI3k/AKT pathway, they are
associated to be linked to the pathogenesis of PE.
- Endothelial glycocalyx (EG), the most important protective structure of the endothelium,
is an external layer of endothelial cells composed of different proteoglycans (PGs),
glycoproteins, glycolipids, and glycosaminoglycans (GAGs). The protective role of EG for
endothelium includes for example maintenance of tissue integrity, prevention of
leukocytes and platelet adhesion and antithrombotic activity (17). Examples of clinical
consequences of EG damage are albuminuria and edema (18).
- Syndecan-1 (SDC-1) is one of the important PGs of EG (19).
- Lead (Pb) is a widespread heavy metal pollutant. Excess Pb in the environment is usually
produced via anthropogenic activities, such as mining and untreated sewage irrigation
water (20).
- Arsenic (Ar) is a major toxicant in the environment, and a high level of exposure
carries an increased risk of cancers and many disorders (21).
- Both of lead and arsenic have been proven to inhibit the PI3K/AKT pathway (22), (23). In
this study, lead (Pb) and arsenic (Ar) will be linked to PE through inhibition of
PI3K/AKT pathway.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03299777 -
Correlation Between Changes in Liver Stiffness and Preeclampsia as Shown by Fibroscan
|
N/A | |
Completed |
NCT03650790 -
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
|
N/A | |
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Not yet recruiting |
NCT03302260 -
Identifying Methods for Postpartum Reduction of Vascular Events: Pilot Randomized Controlled Trial
|
N/A | |
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Completed |
NCT01911494 -
Community Level Interventions for Pre-eclampsia
|
N/A | |
Terminated |
NCT02025426 -
Phenylephrine Versus Ephedrine in Pre-eclampsia
|
Phase 4 | |
Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
Active, not recruiting |
NCT02031393 -
Establishing First Trimester Markers for the Identification of High Risk Twin
|
N/A | |
Terminated |
NCT00141310 -
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
|
Phase 2 | |
Completed |
NCT00157521 -
L-Arginine in Pre-Eclampsia
|
Phase 3 | |
Completed |
NCT04795154 -
Prenatal Yoga as Complementary Therapy of Preeclampsia
|
N/A | |
Completed |
NCT00004399 -
Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia
|
N/A | |
Completed |
NCT00005207 -
Renin and Prorenin in Pregnancy
|
N/A | |
Recruiting |
NCT04551807 -
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
|
Phase 3 | |
Terminated |
NCT04092829 -
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
|
N/A | |
Recruiting |
NCT06067906 -
Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients
|
N/A | |
Recruiting |
NCT06317467 -
Role of Anti-C1q Autoantibodies in Pregnancy
|
||
Completed |
NCT02218931 -
ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
|
N/A | |
Active, not recruiting |
NCT04484766 -
Preeclampsia Associated Vascular Aging
|